Researchers continue to excited about the medication , a novel dual compound showing promising outcomes in initial trials for size loss . It acts by impacting both pathways : GLP-1 and GIP, which , https://miriamvwwr558843.thezenweb.com/a-new-possibility-for-weight-management-79448578